You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 12, December 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Dentistry/ Oral Medicine
 •Dysphagia
 •Laryngology/ Speech/ Language Pathology
 •Neoplasms of Head & Neck
 •Radiation Therapy
 •Rehabilitation Medicine
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Speech and Swallowing Impairment After Treatment for Oral and Oropharyngeal Cancer

Maria-Mercedes Suarez-Cunqueiro, DDS, PhD; Alexander Schramm, DDS, MD, PhD; Ralf Schoen, DDS, MD, PhD; Juan Seoane-Lestón, DDS, MD, PhD; Xosé-Luis Otero-Cepeda, PhD; Kai-Hendrik Bormann, DDS; Horst Kokemueller, MD, DDS; Marc Metzger, MD, DDS; Pedro Diz-Dios, DDS, MD, PhD; Nils-Claudius Gellrich, DDS, MD, PhD

Arch Otolaryngol Head Neck Surg. 2008;134(12):1299-1304.

Objectives  To assess the prevalence of speech and swallowing impairment after radical surgery for oral and oropharyngeal cancer from the patient's viewpoint and to examine the association of these functional alterations with selected clinical characteristics regarding patients, tumors, and oncologic treatment.

Design  Cross-sectional, multicenter study using a self-administered questionnaire.

Setting  Forty-three hospitals in Germany, Switzerland, and Austria.

Patients  A total of 3894 questionnaires about rehabilitation problems after treatment for oral and oropharyngeal squamous cell carcinoma were sent to patients. Of these, 1652 were filled out and returned, and 1334 (80.8%) met the inclusion criteria.

Main Outcome Measures  Morbidity associated with treatment of oral and oropharyngeal cancer.

Results  Speech problems were reported by 851 patients (63.8%), and swallowing problems were reported by 1006 patients (75.4%). The variables that presented a significant association with speech and swallowing impairment were sex, tumor location, pTNM stages, stage of tumor, treatment modality, and reconstruction type.

Conclusions  This survey, based on patient perception, suggests that those who undergo radiotherapy associated with the surgical removal of a tumor, have late-stage tumors (III-IV), or have tumors located in the floor of the mouth should be informed of the greater risk of persistent severe speech and swallowing problems.


Author Affiliations: Department of Oral and Maxillofacial Surgery, Hannover Medical School, Hannover, Germany (Drs Suarez-Cunqueiro, Bormann, Kokemueller, and Gellrich); Department of Oral and Maxillofacial Surgery, German Federal Armed Forces Hospital, Ulm, Germany (Dr Schramm); Departments of Stomatology (Drs Suarez-Cunqueiro, Seoane-Lestón, and Diz-Dios) and Biostatistics (Dr Otero-Cepeda), University Santiago de Compostela, Santiago de Compostela, Spain; and Department of Oral and Maxillofacial Surgery, University Hospital Freiburg, Albert-Ludwigs-University, Freiburg, Germany (Drs Schoen and Metzger).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.